Cinemark Holdings, Inc. (CNK) Shares Sold by Sarasin & Partners LLP
Sarasin & Partners LLP reduced its holdings in Cinemark Holdings, Inc. (NYSE:CNK) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,311,385 shares of the company’s stock after selling 40,723 shares during the quarter. Sarasin & Partners LLP owned 1.12% of Cinemark worth $46,003,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. BlackRock Inc. increased its stake in Cinemark by 2.9% in the 1st quarter. BlackRock Inc. now owns 11,281,416 shares of the company’s stock worth $424,974,000 after acquiring an additional 319,891 shares during the last quarter. Victory Capital Management Inc. increased its stake in Cinemark by 7.2% in the 2nd quarter. Victory Capital Management Inc. now owns 6,535,343 shares of the company’s stock worth $229,260,000 after acquiring an additional 438,400 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Cinemark by 0.6% in the 1st quarter. JPMorgan Chase & Co. now owns 4,103,368 shares of the company’s stock worth $154,574,000 after acquiring an additional 24,258 shares during the last quarter. Eagle Asset Management Inc. bought a new position in Cinemark in the 1st quarter worth about $106,625,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in Cinemark by 3.4% in the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,419,395 shares of the company’s stock worth $91,138,000 after acquiring an additional 79,936 shares during the last quarter. Institutional investors and hedge funds own 96.90% of the company’s stock.
Cinemark opened at $36.78 on Monday, according to MarketBeat. Cinemark Holdings, Inc. has a 12-month low of $32.03 and a 12-month high of $44.00. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.43 and a quick ratio of 1.48. The stock has a market capitalization of $4.30 billion, a PE ratio of 16.27, a PEG ratio of 1.16 and a beta of 0.93.
CNK has been the topic of a number of research analyst reports. Morgan Stanley decreased their target price on Cinemark from $42.00 to $39.00 and set a “$34.56” rating on the stock in a research note on Monday, July 23rd. Wedbush set a $43.00 target price on Cinemark and gave the stock a “buy” rating in a research note on Wednesday, August 8th. B. Riley restated a “buy” rating on shares of Cinemark in a research note on Monday, August 6th. Zacks Investment Research upgraded Cinemark from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a report on Wednesday, July 11th. Finally, ValuEngine upgraded Cinemark from a “sell” rating to a “hold” rating in a report on Thursday, July 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $41.79.
Cinemark Company Profile
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. It operates theatres in the United States, Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay. As of December 31, 2017, the company operated 533 theatres and 5,959 screens.
Further Reading: Diversification For Individual Investors
Want to see what other hedge funds are holding CNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cinemark Holdings, Inc. (NYSE:CNK).
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.